Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Clinical trial NCT02114229 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02114229
Sponsor: St. Jude Children's Research Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Rhabdoid Tumor Atypical Teratoid Rhabdoid Tumor

Start date: 2014-05-14
Primary completion: 2025-09-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.